{
  "revenue_history": [
    0.52,
    0.36,
    0.58,
    0.68
  ],
  "net_profit_history": [
    -4.74,
    -4.81,
    -5.19,
    -4.13
  ],
  "financial_years": [
    "2022",
    "2023",
    "2024",
    "2025"
  ],
  "roe": "-55.4%",
  "net_margin": null
}

{
  "pe": null,
  "pb": "2.5149124",
  "pe_quantile": null,
  "pb_quantile": null,
  "industry_pe": null,
  "dcf": null,
  "pe_history": null,
  "dcf_simple": null,
  "dcf_sensitivity": null
}

{
  "intangible": null,
  "switching": null,
  "network": null,
  "scale": null,
  "scores": {
    "intangible": 5,
    "switching": 5,
    "network": 5,
    "scale": 5
  },
  "rd_summary": null,
  "web_search_snippets": {
    "intangible": [],
    "switching": [],
    "network": [],
    "scale": [],
    "rd": []
  },
  "moat_framework": [
    "intangible",
    "switching",
    "network",
    "scale",
    "efficient_scale"
  ]
}

{
  "kline_count": 501,
  "indicators": {
    "last_close": 13.069999694824219,
    "ma5": 12.5,
    "ma10": 12.239000034332275,
    "ma20": 12.132999992370605,
    "ma60": 11.988833363850912,
    "ma120": 13.101250020662944,
    "ma200": 12.937774991989135,
    "above_ma20": true,
    "above_ma200": true,
    "ma_bull_alignment": false,
    "macd_dif": 0.06367160675515571,
    "macd_dea": -0.030001413987263352,
    "macd_hist": 0.18734604148483813,
    "macd_golden_cross": false,
    "rsi_14": 57.76964975036216,
    "kdj_k": 65.3,
    "kdj_d": 56.2,
    "kdj_j": 83.6,
    "obv": 11031900.0,
    "obv_trend_up": true,
    "williams_r": -10.3,
    "year_high": 27.979999542236328,
    "year_low": 8.039999961853027,
    "pct_from_year_high": -53.28806322854004,
    "stage": 3,
    "vol_5_vs_20": 1.5081503294591856,
    "vcp_score": 0.8316047310760328
  },
  "stage": "Stage 3 顶部",
  "ma_align": "非多头",
  "macd": "中性",
  "rsi": "58",
  "chip_distribution": null,
  "candles_60d": [
    {
      "date": "2026-07-17",
      "open": 11.73,
      "close": 11.38,
      "high": 11.84,
      "low": 11.35
    },
    {
      "date": "2026-07-20",
      "open": 11.52,
      "close": 10.92,
      "high": 11.66,
      "low": 10.91
    },
    {
      "date": "2026-07-21",
      "open": 11.06,
      "close": 11.47,
      "high": 11.56,
      "low": 10.93
    },
    {
      "date": "2026-07-22",
      "open": 11.25,
      "close": 11.13,
      "high": 11.46,
      "low": 11.07
    },
    {
      "da
... (truncated)

{
  "_note": "capital_flow only A-share / HK for now"
}

{
  "_note": "lhb only A-share"
}

{
  "industry": "Biotechnology",
  "self": {
    "code": "NTLA",
    "name": "Intellia Therapeutics, Inc.",
    "industry": "Biotechnology",
    "market_cap": 1831455744,
    "price": 13.07,
    "change_pct": 3.73015,
    "pe_ttm": null,
    "pb": 2.5149124
  },
  "peer_table": null,
  "peer_comparison": null,
  "rank": null,
  "peers_top20_raw": null,
  "fallback_reason": null
}

{
  "main_business_breakdown": null,
  "main_business_raw": null,
  "ths_zyjs": null,
  "products": null,
  "upstream": null,
  "downstream": null,
  "client_concentration": null,
  "supplier_concentration": null,
  "_note": "上下游基于主营/产品/经营范围推断，精确数据需年报附注"
}

{
  "industry": "Biotechnology",
  "growth": null,
  "tam": null,
  "penetration": null,
  "lifecycle": null,
  "note": null,
  "cninfo_metrics": null,
  "total_companies": null,
  "industry_pe_weighted": null,
  "dynamic_snippets": {
    "景气度": [],
    "TAM": [],
    "周期": []
  },
  "needs_web_search": false,
  "web_search_queries": null,
  "_autofill_failed": {
    "query": "Biotechnology 2026 行业增速 TAM 市场规模 渗透率",
    "reason": "MX/ddgs 都没有返回内容"
  }
}

{
  "core_material": null,
  "price_trend": null,
  "price_history_12m": null,
  "materials_detail": null,
  "cost_share": null,
  "import_dep": null,
  "industry_resolved": "NTLA",
  "_autofill_failed": {
    "query": "Intellia Therapeutics, Inc. NTLA 主营业务 主要原材料 成本构成",
    "reason": "MX/ddgs 都没有返回内容"
  }
}

{
  "linked_contract": "无直接关联品种",
  "contract_trend": "海大集团(002311)_公司公告_海大集团：2024年年度报告新浪财经 — Apr 22, 2025 ... 种苗、动…",
  "note": "Biotechnology 行业与期货市场无强相关品种",
  "_autofill": {
    "query": "Biotechnology 行业 上下游 期货品种 套保 大宗",
    "snippet": "海大集团(002311)_公司公告_海大集团：2024年年度报告新浪财经 — Apr 22, 2025 ... 种苗、动保业务同样作为核心业务，是所有动物集约化养殖的基础；两者均有非常强的技术属性，公司将持续投入资源和努力，占领技术和产业；中山百灵生物技术股份有限公司首次公开发行股票并在创业板上市 ... — Jun 9, 2026 ... 特别注意：敬请注意，本招股说明书中部分合计数与各加数直接相加之和. 在尾数上存在差异，均系计算中四舍五入造成。 本招股说明书所引；中山百灵生物技术股份有限公司 — Jun 14, 2026 ... 市场方面，医药制药行业与经济民生息息相关，系国家重点鼓励发",
    "source": "ddgs"
  }
}

{
  "pledge": null,
  "insider_trades_1y": null,
  "qualitative_search": [
    "NTLA 关联交易 违规 处罚",
    "NTLA 股权激励"
  ]
}

{
  "_autofill_failed": {
    "query": "Intellia Therapeutics, Inc. NTLA 最新公告 重大事件 业绩 合同",
    "reason": "MX/ddgs 都没有返回内容"
  }
}

{
  "report_count": 0
}

{
  "rate_cycle": "这篇文章（URL: 网页链接）2026年6月10日发表在 *Nature Biotechnology* 上的深度行业透视... - 雪球 — 这篇文章（URL:…",
  "fx_trend": "中性（人民币走势）",
  "geo_risk": "中性（地缘风险）",
  "commodity": "中性（大宗周期）",
  "industry_macro_impact": "中性",
  "web_search_snippets": {
    "rate_cycle": [],
    "us_rate": [],
    "fx_trend": [],
    "geo_risk": [
      {
        "title": "2026年中美贸易争端大事记（持续更新中）-国际金融与经济研究中心",
        "body": "Sep 22, 2026 · 2026年5月17日： 美国白宫官网发布《事实清单：特朗普总统与中国达成历史性协议》，内容包括中美同意成立中美贸易理事会和中美投资理事会；双方原则上同意在该理事会框架下讨论对等规模的关税降低；中方将回应美国在稀土及其他关键矿产供应链短缺方面 ...",
        "url": "https://cifer.pbcsf.tsinghua.edu.cn/info/1161/3631.htm"
      },
      {
        "title": "2026不断演变的中美贸易关系及企业应对_美国最高法院_关税_中国",
        "body": "Mar 30, 2026 · 2026年3月27日，中国商务部公布对美国实施的贸易壁垒展开两项调查，一项针对“阻碍绿色产品贸易”的贸易措施，另一项针对“扰乱全球生产和供应链”的措施。 调查必须在六个月内完成，但可以再延长三个月。",
        "url": "https://www.sohu.com/a/1003076612_120287836"
      },
      {
        "title": "德恒出口管制经济制裁热点与合规月报（2026年第十三期） - 德恒探索 -...",
        "body": "2026-01-30 时序迈入2026年1月，全球出口管制与经济制裁政策迭代提速，中、美等主要经济体密集出台针对性规制措施，清单调整、执法落地与资讯更新多点发力，为跨境贸易、投资及企业合规经营带来新的挑战与指引。",
        "url": "https://www.dehenglaw.com/CN/tansuocontent/0008/035951/8.aspx?MID=0903"
      }
    ],
    "commodity": [
      {
        "title": "2026年下半年宏观视角下的大宗商品走势分析：大宗商品市场的主线与节...",
        "body": "Jun 30, 2026 · 对资产价格友好，市场预期进一步乐观。 宏观净需求、流动性环境等变化使得大宗商品“超级周期“的基础已不存在。 2026 年下半年，大宗商品自身的属性特征和基本面情况对商品价格影响权重加大。",
        "url": "https://stock.finance.sina.com.cn/stock/go.php/vReport_Show/kind/macro/rptid/836175
... (truncated)

{
  "policy_dir": null,
  "subsidy": null,
  "monitoring": null,
  "anti_trust": null,
  "snippets": {
    "policy_dir": [],
    "subsidy": [],
    "monitoring": [],
    "anti_trust": []
  },
  "year": 2026,
  "industry": "Biotechnology",
  "cfachina_titles_count": 0,
  "_autofill_failed": {
    "query": "Biotechnology 2026 国家政策 监管动态 补贴 税收 影响",
    "reason": "MX/ddgs 都没有返回内容"
  }
}

{
  "xueqiu_heat": "热度 100",
  "thermometer_value": 100,
  "guba_volume": "4 条结果",
  "big_v_mentions": null,
  "positive_pct": "0.0%",
  "sentiment_label": "悲观",
  "platform_snippets": {
    "xueqiu": [
      {
        "title": "Intellia (NTLA) 股票股价_股价行情_财报_数据报告 - 雪球",
        "body": "简介：Intellia Therapeutics, Inc.于2014年5月在特拉华州注册成立。 该公司是一家领先的基因编辑公司，专注于利用最近开发的被称为CRISPR/ Cas9的系统生物工具进行的独特的、潜在治愈疗法的发展。",
        "url": "https://www.xueqiu.com/S/NTLA/finance"
      },
      {
        "title": "Intellia (NTLA) 股票股价_股价行情_财报_数据报告 - 雪球",
        "body": "简介：Intellia Therapeutics, Inc.于2014年5月在特拉华州注册成立。该公司是一家领先的基因编辑公司，专注于利用最近开发的被称为CRISPR/ Cas9的系统生物工具进行的独特的、潜在治愈疗法的发展。公司认为CRISPR/ Cas9技术具有通过单一疗程永久编辑疾病相关的基因在人体内进行改造药物的潜力。该公司打算 ...",
        "url": "https://www.xueqiu.com/S/NTLA/company"
      },
      {
        "title": "Intellia Therapeutics, Inc（NTLA）2026财年公司会议",
        "body": "Intellia Therapeutics, Inc（NTLA）2026财年公司会议 声明:以下内容由机器翻译生成，仅供参考，不构成投资建议。 企业参会人员： John Leonard（总裁兼首席执行官） Edward Dulac（首席财务官） 分析师： Brian Cheng（摩根大通公司） 发言人：Brian Cheng 早上好。感谢大家参加第44届摩根大通医疗健康大会的又一场 ...",
        "url": "https://stockmc.xueqiu.com/202601/b3c11a07-0adf-53e7-a1d3-f47448a7d5e8.html"
      }
    ],
    "guba": [
      {
        "title": "估值分析，以CRISPR、Intellia和Editas公司为例_财富号评论 (cfhpl)股...",
        "body": "Jan 21, 2021 · 4602字4图，阅读大约需要15分钟。 文章首发于丰硕创投，欢迎转发。 今年诺贝尔化学奖花落CRISPR技术，本文就用rNPV法对这三家CRISPR技术公司进行估值分析，尝试找出背后市值差异的逻辑。 1. 创新药估值公式及思路 2. Intellia估值分析 3. Editas估值分析 4. CRISPR估值分析 5. 估值总结 6. 结语 11. 创新药估值 ...",

... (truncated)

{
  "trap_level": "🟢 安全",
  "trap_score": 9,
  "signals_hit": "1/8",
  "signals_hit_count": 1,
  "signals_hit_detail": [
    {
      "id": 6,
      "name": "老师/股神人设推广",
      "evidence_kws": [
        "老师",
        "股神",
        "跟单"
      ],
      "severity": "high"
    }
  ],
  "recommendation": "数据正常，未发现明显推广痕迹。",
  "evidence_count": 3,
  "high_risk_kw": "老师/股神人设推广",
  "snippets": {
    "signal_1": [
      {
        "title": "NTLA股票能买吗？Intellia Therapeutics, Inc股票价格预测与深度分析...",
        "body": "Sep 16, 2026 · NTLA是一只高风险、高回报的股票，适合具有长期视野的激进投资者。 成功的3期试验验证了其CRISPR平台，分析师预计明年收入27.2亿美元，意味着远期市盈率仅1.6倍。 然而，该股尚无收入，市销率14.4倍（较生物科技同行溢价140%），贝塔系数1.77，放大下行风险。",
        "url": "https://bobby.ai/zh-Hans/stocks/NTLA"
      },
      {
        "title": "Intellia Therapeutics (NTLA) Stock Forecast & Price Targets",
        "body": "1 day ago · Stock forecasts and analyst price target predictions for Intellia Therapeutics, Inc. (NTLA) stock, with detailed revenue and earnings estimates.",
        "url": "https://stockanalysis.com/stocks/ntla/forecast/"
      }
    ],
    "signal_2": [
      {
        "title": "章建平：但凡主力建仓完毕，股价在拉升前，都会出现这三个信号！",
        "body": "Mar 25, 2026 · 但凡主力建仓完毕，股价在拉升前，都会出现三个核心信号，只要学会识别这三个信号，就能精准把握主力拉升时机，轻松跟随主力享受主升浪收益，简单易懂、可操作性强，无论是老股民还是新手，都能快速上手，摆脱“追涨杀跌”的困境。",
        "url": "https://www.toutiao.com/article/7621187046840795658/"
      },
      {
        "title": "主力建仓完毕即将拉升，“成交量”都会出现这样的特征！",
        "body": "Mar 19, 2026 · 尤其是主力完成建仓、准备拉升之前，成交量一定会露出非常明显、非常统一的特征。 今天这篇文章，我就把主力建
... (truncated)

{
  "xueqiu_cubes": null,
  "xueqiu_meta": {
    "http_status": 200,
    "source": "http",
    "login_required": true,
    "hint": "set UZI_XQ_LOGIN=1 + run `python -m lib.xueqiu_browser login` (one-time)"
  },
  "tgb_mentions": [
    {
      "error": "tgb fetch failed: HTTPSConnectionPool(host='www.taoguba.com.cn', port=443): Max retries exceeded with url: /Article/list/all?keyword=NTLA (Caused by SSLError(SSLCertVerificationError(1, \"[SSL: CERTIFICATE_VERIFY_FAILED] certificate verify failed: Hostname mismatch, certificate is not valid for 'www.taoguba.com.cn'. (_ssl.c:992)\")))"
    }
  ],
  "ths_simu": [
    {
      "note": "ths simu endpoint requires login or blocked"
    }
  ],
  "dpswang": null,
  "summary": {
    "xueqiu_cubes_total": 0,
    "high_return_cubes": 0,
    "s_tier_holders": 0,
    "a_tier_holders": 0,
    "b_tier_holders": 0,
    "tgb_mentions_count": 0,
    "ths_evidence_count": 0,
    "xueqiu_login_required": true,
    "xueqiu_source": "http"
  },
  "fallback_queries": [
    "淘股吧 实盘 NTLA 持仓",
    "挑战者杯 NTLA",
    "雪球 实盘组合 NTLA 50%",
    "全国期货实盘大赛 NTLA"
  ],
  "_note": "⚠️ XueQiu cubes 接口 2026 起需登录。当前未启用 Playwright 登录，0 cube 收录。如需启用：export UZI_XQ_LOGIN=1 然后 python -m lib.xueqiu_browser login 一次性登录。或 --skip-login-sources 接受跳过（其他维度不影响）。"
}